Social Interaction and Communities of Practice in Formative Period NW Argentina: A Multi-analytical Study of Ceramics

This is the author accepted manuscript. The final version is available from University of New Mexico Press via the link in this recordThe study of long-distance exchange of goods and resources has long been central to the understanding of socio-political and cultural complexity in the south-central Andes. Traditional studies have emphasized typological similarities to reconstruct regional networks, proposing the dominance of different centres through time. While these approaches were informative on the general direction of contacts, the nature and scale of interaction has remained speculative. This chapter summarises the latest results of our ongoing research project on long-distance circulation of archaeological materials in northwestern Argentina during part of the Formative Period (ca. 1500 BC-AD 1000). The study applied a multianalytical methodological strategy integrating archaeological analysis with archaeometric techniques, including thin section petrography, instrumental neutron activation analysis (INAA) and laser ablation inductively coupled massspectometry (LA-ICP-MS) in order to contribute an evidence-based holistic view of preHispanic exchange networks. The study examined materials traditionally studied separately, including 542 ceramic samples and 113 obsidian and volcanic rock artifacts, from seven sectors in the semi-arid valleys area. We summarize here the results of the ceramic analysis, showing the 19-2 following trends: (1) inter-valley heterogeneity of clay and fabrics for ordinary wares; (2) intervalley homogeneity of clay and fabrics for a wide range of decorated wares; (3) selective circulation of two distinct polychrome wares. These trends reflect the complex inter-community relationships experienced in small-scale societies. The study offers a new platform to model ancient exchange, and circulation and interaction more broadly, based on actual material transfers. The results call for the re-examination of the centralized models of exchange and interaction that are often drawn upon to account for emergent cultural complexity in the past, both in the Andes and beyond.British AcademyArts and Humanities Research Council (AHRC)Argentinean National Agency for Science and Technology (ANPCyT)Raíces ProgramArgentinian National Council for Scientific and Technical Research (CONICET

Para usar en la cocina. Adquisición, producción y uso de artefactos líticos en la Estructura 1 de Cardonal (Valle del Cajón, Catamarca)

This paper presents the reconstruction of lithic knapping activities carried out within Structure 1 of Compound 1 in the Cardonal archaeological site (Cajón Valley, Catamarca) at the beginning of the Christian Era. The study of this structure, interpreted as the house kitchen, allowed us to analyze microscale technological processes, and so address the sum of technical actions that constituted daily life within the house. We evaluated the selection of lithic resources chosen by the inhabitants of the house and studied artifact variability within the lithic assemblage recovered, thereby identifying the lithic technological activities that occurred in the room. The methodology employed and the results obtained allowed us to determine the diversity of rocks used, as well as to reconstruct a wide range of lithic production activities. We focused on lithic technology embedded in everyday practices within network frameworks that included not only other Cardonal residents, but also more distant people and landscapes.En este trabajo se propone la reconstrucción de las actividades de talla lítica llevadas a cabo en la Estructura 1 del Núcleo 1 del sitio arqueológico Cardonal en el valle del Cajón (Catamarca) a comienzos de la Era Cristiana. El estudio de este recinto, interpretado como la cocina de la casa, permitió analizar procesos tecnológicos microescalares para considerar el flujo de acciones técnicas incluidas en la realidad cotidiana de una vivienda. Aquí se evalúa la elección de recursos líticos por parte de los residentes en la casa, se estudia la variabilidad artefactual en el conjunto lítico recuperado y se identifican las actividades tecnológicas líticas ocurridas en esta habitación. La metodología aplicada y los resultados obtenidos permitieron determinar la diversidad de rocas utilizadas, como también reconstruir una extensa gama de actividades de producción lítica. Se entiende a la tecnología lítica como inmersa en las prácticas cotidianas en el marco de redes de relaciones que comprendían no sólo a otros habitantes de Cardonal, sino también a personas y paisajes distantes

Bernardo Dougherty 1941-1997

Fil: Scattolin, María Cristina. Universidad Nacional de La Plata. Facultad de Ciencias Naturales y Museo; ArgentinaFil: Scattolin, María Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina.Fil: Fernández, Ana M. Universidad Nacional de La Plata. Facultad de Ciencias Naturales y Museo. Departamento Arqueología; Argentin

Synthesis and anticancer activity of Pt(0)-olefin complexes bearing 1,3,5-triaza-7-phosphaadamantane and N-heterocyclic carbene ligands

A series of Pt(0)-η2-olefin complexes bearing 1,3,5-triaza-7-phosphaadamantane (PTA) or N-heterocyclic carbenes are prepared following different synthetic strategies depending on the nature of coordinated alkene and spectator ligands. These new platinum(0) derivatives have been tested in vitro as anticancer agents toward three different tumor (human ovarian cancer A2780 and A2780cis and K562 myelogenous leukemia) and one non-tumor (Hacat keratinocytes) cell lines, proving to be in several cases highly and selectively cytotoxic against ovarian cancer cells. Furthermore, this antiproliferative effect is associated with the activation of an apoptosis process. In particular, complexes equipped with PTA as spectator ligand give comparable IC50 values on A2780 (cisplatin sensitive) and A2780cis (cisplatin resistant) cell lines, indirectly proving that these new Pt(0) substrates act with a mechanism of action conceivably different from cisplatin. This hypothesis is also confirmed by the fact that our compounds, in contrast to cisplatin, are not able to promote erythroid-differentiation activity on the K562 myelogenous leukemia cell line

The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer

A new dinuclear Pd(i) complex coordinating two bis(NHC) ligands revealed an unsuspected stability despite the unsaturation of the two metal centres. Even more surprisingly, the compound showed high and selective antiproliferative activity against different cancer cell lines and ovarian cancer tumoroids, and the mechanism of action was different from that of cisplatin

The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer

A new dinuclear Pd(i) complex coordinating two bis(NHC) ligands revealed an unsuspected stability despite the unsaturation of the two metal centres. Even more surprisingly, the compound showed high and selective antiproliferative activity against different cancer cell lines and ovarian cancer tumoroids, and the mechanism of action was different from that of cisplatin

Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands

New palladacyclopentadienyl complexes with bis-N-heterocyclic carbenes as spectator ligands have been synthesized and exhaustively characterized. The crystal structure of complex 1a has been also determined by X-ray diffraction analysis. Their in vitro cytotoxicity and that of other palladacyclopentadienyl derivatives coordinating different ancillary ligands has been determined against different cancer cell lines. Many complexes have shown an antiproliferative activity toward tumor cells often definitely better than cisplatin, whereas they have resulted practically inactive against the non-cancer MRC-5 cell line. The mechanism of action of bis-NHC derivative 1a, particularly active against ovarian cancer cell lines was studied in depth. Through a longitudinally analysis, it is shown that compound 1a induces apoptosis via DNA damage and release of cytochrome C. We propose compound 1a as a powerful and specific drug for the therapy of a deadly disease such as high grade serous ovarian cancer

Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines

Aims: This study describes real-world outcomes of pretreated EGFR T790M-positive (T790M+) advanced non-small-cell lung cancer patients progressing after first- or second-generation tyrosine kinase inhibitors and receiving osimertinib, compared with T790M-negative (T790M-) patients. We have also described progression patterns and treatment sequences. Patients & methods: This is a retrospective multicenter Italian observational study including consecutive Caucasian patients referred between 2014 and 2018. Results: 167 patients were included. Median progression-free survival was 9.8 months (95% CI: 8.3-13.3) for T790M+ and 6.0 months (95% CI: 4.9-7.2) for T790M- patients, respectively. Median overall survival was 20.7 months (95% CI: 18.9-28.4) for T790M+ and 10.6 months (95% CI: 8.6-23.6) for T790M- patients, respectively. The T790M mutation correlated with absence of new sites of disease. After progression, most T790M+ patients continued osimertinib, whereas most T790M- patients received a different treatment line. Conclusion: Better outcomes were shown in patients receiving osimertinib. A more limited progression pattern for T790M+ was suggested

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

Secondary acute myeloid leukemia (sAML) poorly responds to conventional treatments and allogeneic stem cell transplantation (HSCT). We evaluated toxicity and efficacy of CPX-351 in 71 elderly patients (median age 66 years) with sAML enrolled in the Italian Named (Compassionate) Use Program. Sixty days treatment-related mortality was 7% (5/71). The response rate at the end of treatment was: CR/CRi in 50/71 patients (70.4%), PR in 6/71 (8.5%), and NR in 10/71 (19.7%). After a median follow-up of 11 months relapse was observed in 10/50 patients (20%) and 12 months cumulative incidence of relapse (CIR) was 23.6%. Median duration of response was not reached. In competing risk analysis, CIR was reduced when HSCT was performed in first CR (12 months CIR of 5% and 37.4%, respectively, for patients receiving (=20) or not (=30) HSCT, p = 0.012). Twelve-months OS was 68.6% (median not reached). In landmark analysis, HSCT in CR1 was the only significant predictor of longer survival (12 months OS of 100 and 70.5%, for patients undergoing or not HSCT in CR1, respectively, p = 0.011). In conclusion, we extend to a real-life setting, the notion that CPX is an effective regimen for high risk AML patients and may improve the results of HSCT

Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study

Within the Campus ALL network we analyzed the incidence, characteristics, treatment and outcome of a central nervous system (CNS) relapse in 1035 consecutive adult acute lymphoblastic leukemia (ALL) patients treated frontline with pediatric-inspired protocols between 2009 and 2020. Seventy-one patients (6.8%) experienced a CNS recurrence, more frequently in T- (28/278; 10%) than in B-ALL (43/757; 5.7%) (p = 0.017). An early CNS relapse—< 12 months from diagnosis—was observed in 41 patients. In multivariate analysis, risk factors for early CNS relapse included T-cell phenotype (p = <0.001), hyperleucocytosis >100 × 109/L (p<0.001) and male gender (p = 0.015). Treatment was heterogeneous, including chemotherapy, radiotherapy, intrathecal therapy and novel agents. A complete remission (CR) was obtained in 39 patients (55%) with no differences among strategies. After CR, 26 patients underwent an allogenic transplant, with a significant overall survival benefit compared to non-transplanted patients (p = 0.012). After a median observation of 8 months from CNS relapse, 23 patients (32%) were alive. In multivariate analysis, the time to CNS relapse was the strongest predictor of a lower 2-year post-relapse survival (p<0.001). In conclusion, in adult ALL the outcome after a CNS relapse remains very poor. Effective CNS prophylaxis remains the best approach and allogenic transplant should be pursued when possible